International Patent: IDENTIFICATION OF MUC1-C AS A TARGET FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMAS

GENEVA, July 31 -- DANA-FARBER CANCER INSTITUTE, INC. filed a patent application (US2025/024273) for “IDENTIFICATION OF MUC1-C AS A TARGET FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMAS”. With publication no. WO/2025/217515, here are the other details related to the patent application:

Kind: Corrected version of pamphlet [A9]

IPC: A61K 38/08

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....